Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
Clicks: 297
ID: 8056
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
81.1
/100
297 views
237 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B| Reference Key |
zheng2019comparisoninfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Caixia Zheng;Honghong Yan;Jianyong Zeng;Shaohang Cai;Xiaolu Wu; |
| Journal | Infection and drug resistance |
| Year | 2019 |
| DOI | 10.2147/IDR.S195144 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.